Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings
Filings indexed
951
across all filing types
Latest filing
2025-11-04
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
SNOA
Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 10-Q FOR SEP 2025 | 2025-11-04 | English | |
| FORM 8-K | 2025-10-23 | English | |
| CURRENT REPORT | 2025-10-09 | English | |
| CURRENT REPORT | 2025-09-29 | English | |
| CURRENT REPORT | 2025-09-26 | English | |
| PROSPECTUS SUPPLEMENT | 2025-09-26 | English |
Browse filings by year
21 years- 2026 15 filings
- 2025 33 filings
- 2024 33 filings
- 2023 40 filings
- 2022 29 filings
- 2021 26 filings
- 2020 34 filings
- 2019 31 filings
- 2018 53 filings
- 2017 64 filings
- 2016 53 filings
- 2015 64 filings
- 2014 50 filings
- 2013 54 filings
- 2012 44 filings
- 2011 60 filings
- 2010 40 filings
- 2009 85 filings
- 2008 44 filings
- 2007 67 filings
- 2006 32 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 11994865 | FORM 10-Q FOR SEP 2025 | 2025-11-04 | English | ||
| 11994869 | FORM 8-K | 2025-10-23 | English | ||
| 11994872 | CURRENT REPORT | 2025-10-09 | English | ||
| 11994877 | CURRENT REPORT | 2025-09-29 | English | ||
| 11994878 | CURRENT REPORT | 2025-09-26 | English | ||
| 11994881 | PROSPECTUS SUPPLEMENT | 2025-09-26 | English | ||
| 11994880 | FORM 8-K | 2025-08-29 | English | ||
| 11994886 | FORM 10-Q FOR JUNE 2025 | 2025-08-07 | English | ||
| 11994884 | DEFINITIVE PROXY STATEMENT | 2025-07-11 | English | ||
| 11994887 | Director's Dealing 2025 | 2025-06-20 | English | ||
| 11994888 | Director's Dealing 2025 | 2025-06-20 | English | ||
| 11994889 | Director's Dealing 2025 | 2025-06-20 | English | ||
| 11994890 | Director's Dealing 2025 | 2025-06-20 | English | ||
| 11994896 | REGISTRATION STATEMENT | 2025-06-17 | English | ||
| 11994893 | FORM 10-K FOR MARCH 2025 | 2025-06-17 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Sonoma Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35312/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35312 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35312 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35312 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35312}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Sonoma Pharmaceuticals, Inc. (id: 35312)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.